Search

Meet Sandra Lowe, who was diagnosed with lung cancer in February 2021 and was treated successfully at Memorial Sloan Kettering Cancer Center.

… Thursday, September 26, 2024 Sandra Lowe’s lung cancer lung cancer diagnosis came out of nowhere. She was 63, healthy and living an active life near Albany, New York, working full-time at a credit union, hiking the Adirondack Mountains with her husband, and visiting her two sons in Boston. When a routine

Esta es Sandra Lowe, a quien le diagnosticaron cáncer pulmonar en febrero de 2021 y fue tratada con éxito en el Memorial Sloan Kettering Cancer Center.

… Thursday, September 26, 2024 El diagnóstico de cáncer pulmonar cáncer pulmonar de Sandra Lowe surgió de repente. Tenía 63 años, era una persona saludable y llevaba una vida activa cerca de Albany, Nueva York. Trabajaba a tiempo completo en una cooperativa de crédito, caminaba por las montañas Adirondack

He was given a wrong diagnosis. A blood test changed his life.

… Wednesday, March 20, 2019 Summary A noninvasive genetic test known as liquid biopsy is helping doctors choose the best treatment for their patients based on the unique characteristics of their tumors. When 34-year-old Joey Laurore came to Memorial Sloan Kettering in 2017, he was looking for a second

The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.

… Thursday, November 2, 2017 Summary A new technique allows scientists to see macrophages in tumors by the way they concentrate iron. Macrophages, a type of immune cell, can influence how well a person fares on cancer treatment . The technique is noninvasive and could one day help doctors tailor treatments

MSK's experts in molecular pathology are finding new clues about these tumors.

… Tuesday, July 31, 2018 Summary Sarcomas make up only about 1% of all cancers, yet there are more than 50 different types. Receiving a diagnosis of sarcoma can be overwhelming. But it can be especially confusing because many people have never heard of sarcoma and many doctors have never treated it. It

Learn what to expect from early menopause.

… Thursday, August 16, 2018 Summary Women undergoing procedures for cancer prevention or treatment may begin menopause earlier than other women. Here is a primer on what they can expect. Ovaries may be small, but they pack a powerful punch. These grape-size organs secrete hormones, produce and house eggs

MSK research provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis of brain diseases by revealing how different parts of the brain are metabolizing nutrients; describes a new method to aid the study of rare but influential cell populations; and identifies a potential treatment for malignant peripheral nerve sheath tumors.

… Friday, January 17, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) provides a clearer understanding of glioblastoma heterogeneity to aid development of new therapies; sheds light on mechanisms of cellular plasticity; presents a new imaging technique that could improve the diagnosis

Hedvig Hricak, Chair of Memorial Sloan Kettering's Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors.

… Monday, February 1, 2010 Summary Hedvig Hricak, Chair of Memorial Sloan Kettering’s Department of Radiology and incumbent of the Carroll and Milton Petrie Chair, has been named the 95th President of the Radiological Society of North America Board of Directors. Hedvig Hricak , Chair of Memorial Sloan

About two dozen MSK physicians and researchers shared their work at the world’s leading breast cancer conference, held annually in San Antonio.

… Friday, December 13, 2019 At the annual San Antonio Breast Cancer Symposium, MSK investigators presented the latest research on detection and screening methods for people at high risk; immunotherapy for breast cancer; and the underlying causes of resistance to targeted therapies, among other topics.

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:

… Friday, August 15, 2025 Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:  MSK’s financial performance for the first half of 2025 resulted in a deficiency of operating revenues over expenses of $(113.2) million